Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Mechanistic Models: Compartment Models in Individual and Population Analysis01:23

Mechanistic Models: Compartment Models in Individual and Population Analysis

86
Mechanistic models are utilized in individual analysis using single-source data, but imperfections arise due to data collection errors, preventing perfect prediction of observed data. The mathematical equation involves known values (Xi), observed concentrations (Ci), measurement errors (εi), model parameters (ϕj), and the related function (ƒi) for i number of values. Different least-squares metrics quantify differences between predicted and observed values. The ordinary least...
86
Mechanistic Models: Overview of Compartment Models01:21

Mechanistic Models: Overview of Compartment Models

162
Mechanistic models, a category encompassing both physiological and compartmental modeling, differ from empirical models' approaches to incorporating known factors about the systems being modeled. Empirical models describe data with minimal assumptions, while mechanistic models aim to provide a robust description of available data by specifying assumptions and integrating known factors about the system. Compartmental analysis is a key example of a mechanistic model in pharmacokinetics and...
162
Clearance Models: Noncompartmental Models01:17

Clearance Models: Noncompartmental Models

100
Clearance is a pharmacokinetic parameter traditionally defined by compartment models, signifying the rate at which a drug is expelled from the body. However, a noncompartmental model offers an alternative method for assessing clearance, primarily employing empirical data obtained after administering a single drug dose.
The noncompartmental approach capitalizes on extensive sampling data, correlating the volume of distribution to systemic exposure and the administered dosage. This method enables...
100
Multicompartment Models: Overview01:14

Multicompartment Models: Overview

258
Multicompartment models are mathematical constructs that depict how drugs are distributed and eliminated within the body. They segment the body into several compartments, symbolizing various physiological or anatomical areas connected through drug transfer processes such as absorption, metabolism, distribution, and elimination.
These models offer a more comprehensive representation of drug behavior in the body than one-compartment models. They accommodate the complexity of drug distribution,...
258
Compartment Models: Two-Compartment Model01:20

Compartment Models: Two-Compartment Model

6.0K
The two-compartment model divides the body into central and peripheral compartments to account for varying blood perfusion rates among organs and tissues, affecting drug distribution. The central compartment includes blood and highly perfused tissues with rapid drug distribution, while the peripheral compartment contains tissues with slower drug distribution. After a single IV bolus dose, the drug concentration is high in plasma and low in tissues. The drug distribution between compartments...
6.0K
Parameters Affecting Nonlinear Elimination: Zero-Order Input, First-Order Absorption and Two-Compartment Model01:13

Parameters Affecting Nonlinear Elimination: Zero-Order Input, First-Order Absorption and Two-Compartment Model

126
Drugs administered through various routes can lead to nonlinear elimination, resulting in complex pharmacokinetic behaviors crucial to understanding efficacious drug dosing.
When a drug is administered through a constant intravenous infusion and eliminated via nonlinear pharmacokinetics, it follows zero-order input. For example, oral drugs undergo first-order absorption upon administration and are eliminated through nonlinear pharmacokinetics.
In the case of subcutaneously administered drugs,...
126

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Three-arm randomised controlled trial of text message reminders and financial incentives to improve antidepressant adherence among adults in primary care with depression: study protocol.

BMJ open·2026
Same author

Adjunctive Psychosocial Interventions and Opioid Abstinence Among Patients Receiving Buprenorphine: A Randomized Clinical Trial.

JAMA network open·2026
Same author

Adiposity and inflammation mediate altered metabolic profile in individuals with opioid use disorder.

Journal of psychiatric research·2026
Same author

Sex Differences in Fall Frequency, Risk Factors, and Outcomes in Parkinson's Disease: A Cross-Sectional Analysis.

Movement disorders clinical practice·2026
Same author

Translating the ABCSs into HIV Care: A Stepped Wedge Cluster Randomized Clinical Trial.

Journal of general internal medicine·2026
Same author

Adiposity and inflammation mediate altered metabolic profiles in individuals with opioid use disorder.

medRxiv : the preprint server for health sciences·2026

Related Experiment Video

Updated: Sep 12, 2025

Applying an eMASS Customization Program as a Research Tool to Evaluate Consumer Benefits
08:27

Applying an eMASS Customization Program as a Research Tool to Evaluate Consumer Benefits

Published on: September 27, 2019

7.0K

A MARGINAL STRUCTURAL MODEL FOR PARTIAL COMPLIANCE IN SMARTS.

By William J Artman1, Indrabati Bhattacharya2, Ashkan Ertefaie1

  • 1Department of Biostatistics and Computational Biology, University of Rochester Medical Center.

The Annals of Applied Statistics
|August 7, 2025
PubMed
Summary

This study introduces a new statistical method to analyze complex treatment data for substance use disorders. The findings show that optimal treatment plans (dynamic treatment regimes) must consider patient compliance levels for better engagement.

Keywords:
Dynamic treatment regimemarginal structural modelsnonparametric Bayespartial complianceprincipal stratificationsequential multiple assignment randomized trial

More Related Videos

Author Spotlight: Validation of SICOLE-R for Assessing Cognitive and Reading Skills in Spanish-Speaking Children and Its Role in Personalized Education
09:00

Author Spotlight: Validation of SICOLE-R for Assessing Cognitive and Reading Skills in Spanish-Speaking Children and Its Role in Personalized Education

Published on: August 16, 2024

912
Modeling Verbal Behavior Deficits with the Stimulus Control Ratio Equation, SCoRE
06:57

Modeling Verbal Behavior Deficits with the Stimulus Control Ratio Equation, SCoRE

Published on: May 14, 2019

10.6K

Related Experiment Videos

Last Updated: Sep 12, 2025

Applying an eMASS Customization Program as a Research Tool to Evaluate Consumer Benefits
08:27

Applying an eMASS Customization Program as a Research Tool to Evaluate Consumer Benefits

Published on: September 27, 2019

7.0K
Author Spotlight: Validation of SICOLE-R for Assessing Cognitive and Reading Skills in Spanish-Speaking Children and Its Role in Personalized Education
09:00

Author Spotlight: Validation of SICOLE-R for Assessing Cognitive and Reading Skills in Spanish-Speaking Children and Its Role in Personalized Education

Published on: August 16, 2024

912
Modeling Verbal Behavior Deficits with the Stimulus Control Ratio Equation, SCoRE
06:57

Modeling Verbal Behavior Deficits with the Stimulus Control Ratio Equation, SCoRE

Published on: May 14, 2019

10.6K

Area of Science:

  • Statistics
  • Biostatistics
  • Data Science

Background:

  • Substance use disorders (SUDs) are complex, requiring adaptive treatment strategies.
  • Longitudinal data from trials like ENGAGE offer potential for personalized dynamic treatment regimes (DTRs).
  • Noncompliance and lack of analytical tools hinder the use of such data for tailoring SUD treatments.

Purpose of the Study:

  • To develop and validate a statistical method for constructing DTRs that account for patient compliance in SUD treatment.
  • To address limitations in analyzing longitudinal data with noncompliance in randomized trials.

Main Methods:

  • Proposed a marginal structural model incorporating principal stratification to estimate treatment effects across compliance strata.
  • Utilized a Bayesian semiparametric approach to model principal strata, considering partial compliance.
  • Assessed method performance via simulation and applied it to the ENGAGE trial data.

Main Results:

  • The proposed method effectively estimates treatment effects considering partial compliance strata.
  • Optimal DTRs were found to be dependent on compliance levels, unlike intention-to-treat analyses.
  • Demonstrated the importance of accounting for compliance in developing personalized SUD treatment strategies.

Conclusions:

  • The developed statistical framework enables the construction of individually tailored DTRs for SUDs by accounting for compliance.
  • This approach offers a significant advancement over traditional methods like intention-to-treat analysis for longitudinal treatment studies.
  • Highlights the critical role of compliance in optimizing treatment engagement and outcomes for individuals with SUDs.